Biomarker identification in the realm of rare diseases
Drug Target Review
MAY 7, 2024
Why are biomarkers particularly critical in the context of rare diseases? Developing novel therapeutic approaches for rare diseases poses inherent challenges due to the limited populations available for testing. How do AI-enhanced approaches accelerate the drug development process for rare diseases?
Let's personalize your content